SinoFresh signs leter-of-intent with National Starch and Chemical
ENGLEWOOD, Fla. SinoFresh HealthCare earlier this week announced its non-binding letter-of-intent signed with National Starch and Chemical Co. to develop new versions of popular allergy-related over-the-counter medicines.
The company is targeting March 2008 for launch.
The new products will utilize National Starch’s proprietary patented Proloc bio-adhesive technology to deliver the drug formulations.
“In the United States, our current nasal spray has been aimed at helping the 37 million people who suffer from Chronic Sinusitis. By developing new and improved allergy-related formulations, we expect to help an additional 50 million people who suffer from allergies,” stated SinoFresh chief executive officer Charles Fust.
Bioforce elects not to participate in NAD inquiry
NEW YORK The National Advertising Division of the Council of Better Business Bureaus on Monday referred advertising from Bioforce USA for Sanhelios Curbita Bladder Caps to the Federal Trade Association and the Food and Drug Administration following the company’s refusal to participate in an NAD proceeding.
Claims made by Bioforce that were at issue in print and internet advertising included:
- “Sanhelios found that the oil derived from a special species of pumpkinseed, Curbita provides a unique ability to enhance bladder function for men and women.”
- “Pumpkin Seed Oil supports the entire system of bladder muscles.”
- “This capsule holds the secret for strengthening the bladder.”
- “Curbita Bladder Caps has the unique ability to enhance bladder function for men and women”
- “It helps strengthen bladder muscles while supporting normal emptying of the bladder through the calming effect of this high dosage pumpkin power capsule.”
- “It supports normal emptying of the bladder because Curbita has a calming and harmonizing effect on the function of bladder muscles. This leads to a strengthening of the functional-urinary system for mean and women.”
- “Sanhelios found that high dosages of Curbita, pumpkins, have a unique ability to enhance bladder function, leading to a strengthening of the bladder muscles as well as the functional-urinary system.”
- “For a strong , healthy bladder, try Curbita”
The advertiser, in response to NAD’s inquiry, advised NAD that it had elected not to participate in the NAD review proceeding because the challenge was initiated by the Council of Responsible Nutrition. The advertiser contended that because CRN has funded the expansion of NAD’s review of dietary-supplement advertising, the advertiser believed the challenge to be improper.
NAD, in its decision, noted that it was disappointed by the advertiser’s decision not to provide a substantive response, especially in light of the strong health-related claims being made in the advertising.
Novartis introduces Canada’s Buckley’s cough medicine to U.S. market
PARSIPPANY, N.J. Novartis is bringing Buckley’s, Canada’s No. 1 cough product—according to Information Resources, Inc. data for the 52 weeks ended Aug. 4—to the U.S. market. The brand will be introduced with two SKUs: a cough suppressant mixture and a chest congestion mixture that includes an expectorant.
Buckley’s point of differentiation is its bad taste with the slogan “It tastes awful. And it works.” The cough syrup is both sugar- and alcohol-free and includes camphor, Canadian fir balsam gum, pine needle oil and menthol.
To help generate interest in its U.S. debut, Novartis is sponsoring an online photo contest that invites people to post images of themselves tasting Buckley’s. The contest kicks off Nov. 5 and runs for one month. Entrants will have a chance to win an Alaskan Adventure vacation for two.
“There are two kinds of people in this world—those who what comfort when they are sick and those who want to get better,” stated Jose Rodriguez, Novartis Consumer Health vice president of marketing. “Buckley’s is for people who are focused on getting back to feeling like themsevels again quickly.”
According to Novartis, 65 percent of U.S. households purchased a cough remedy in the last year.